Translational Research Institute for Metabolism and Diabetes - Academic Profile

Publications

Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes

Christopher P. Cannon , Richard E. Pratley , Samuel Dagogo‐Jack +12 more

Among patients with type 2 diabetes and atherosclerotic cardiovascular disease, ertugliflozin was noninferior to placebo with respect to major adverse cardiovascular events. (Fu...

2020 New England Journal of Medicine 1396 citations

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Naveed Sattar , Matthew M.Y. Lee , Søren Lund Kristensen +9 more

2021 The Lancet Diabetes & Endocrinology 1304 citations

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes

Darren K. McGuire , Weichung Shih , Francesco Cosentino +11 more

In this meta-analysis, SGLT2 inhibitors were associated with a reduced risk of major adverse CV events; in addition, results suggest significant heterogeneity in associations wi...

2020 JAMA Cardiology 1070 citations

Institution Info

Type: facility
Country: US
Publications: 3
Citations: 3,770

External Links

Identifiers

ROR: https://ror.org/03gj9g134